The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 31, 2015

Filed:

Feb. 22, 2008
Applicants:

Barry Forman, Irvine, CA (US);

Donna Yu, Arcadia, CA (US);

Inventors:

Barry Forman, Irvine, CA (US);

Donna Yu, Arcadia, CA (US);

Assignee:

City of Hope, Duarte, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A01N 37/12 (2006.01); A01N 37/44 (2006.01); A61K 31/195 (2006.01); C07C 229/00 (2006.01); C07C 217/18 (2006.01);
U.S. Cl.
CPC ...
A61K 31/195 (2013.01); C07C 217/18 (2013.01);
Abstract

LXR nuclear receptor agonists have been previously shown to increase cholesterol efflux, raise plasma HDL cholesterol, stimulate cholesterol excretion, and reduce atherosclerotic lesions. However, these agonists have also been associated with the unwanted side effect of hypertriglyeridemia. This hypertriglyeridemia appears to be mediated by the LXRα subtype rather than LXRβ, which suggests that LXRβ-selective agonists are attractive candidates for modulation of human lipid metabolism. The present application provides novel LXRβ-selective ligands that preferably modulate LXRβ over LXRα. These ligands may be used to treat a variety of diseases associated with LXR, such as for example lipid metabolism disorders, atherosclerosis, Alzheimer disease, and inflammation.


Find Patent Forward Citations

Loading…